Trials / Recruiting
RecruitingNCT04891510
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 135 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | REVOLVE Advanced Adipose System | The REVOLVE system is an all-in-one fat processing device that harvests, filters, actively washes, and removes strands from lipoaspirate and allows for reinjection without any additional manipulation (REVOLVE 2020). |
| DEVICE | LipoGrafter | The LipoGrafter system is designed to be a start-to-finish closed system with minimal processing of the lipoaspirate, minimizing the risk of contamination and fat cell damage (LipoGrafter 2020). |
| PROCEDURE | Viality | The Viality system uses the AuraClens solution that acts as a surfactant to bring impurities like blood, free oil, and cellular debris into solution, where they can be flushed out through suction. |
Timeline
- Start date
- 2021-05-19
- Primary completion
- 2027-01-01
- Completion
- 2027-01-01
- First posted
- 2021-05-18
- Last updated
- 2025-07-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04891510. Inclusion in this directory is not an endorsement.